$112 Million is the total value of NanoDimension, Inc.'s 4 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | ICOSAVAX INC | $62,920,000 | – | 2,749,994 | +100.0% | 56.41% | – | |
| TWST | New | TWIST BIOSCIENCE CORP | $23,816,000 | – | 307,740 | +100.0% | 21.35% | – |
| SQZ | New | SQZ BIOTECHNOLOGIES CO | $12,906,000 | – | 1,445,221 | +100.0% | 11.57% | – |
| SELB | New | SELECTA BIOSCIENCES INC | $11,892,000 | – | 3,647,907 | +100.0% | 10.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-23
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICOSAVAX INC | 4 | Q3 2022 | 56.4% |
| TWIST BIOSCIENCE CORP | 4 | Q3 2022 | 44.0% |
| SELECTA BIOSCIENCES INC | 4 | Q3 2022 | 25.2% |
| SQZ BIOTECHNOLOGIES CO | 4 | Q3 2022 | 15.2% |
View NanoDimension, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-05-11 |
| 13F-HR | 2022-02-23 |
View NanoDimension, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.